Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma
Clinical trial NCT05889221 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05889221
- Sponsor
- Poitiers University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-23
- Primary completion
- 2026-03-16
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.